JCM
GPCR icon

Janney Capital Management’s Structure Therapeutics GPCR Stock Holding History

Janney Capital Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$592K Sell
8,513
-5,205
-38% -$213K 0.04% 160
2025
Q3 		$384K Buy
+13,718
New +$273K 0.02% 181
2025
Q1 		– Sell
-9,007
Closed -$244K – 240
2024
Q4 		$244K Buy
9,007
+2,405
+36% +$85.3K 0.02% 231
2024
Q3 		$290K Buy
+6,602
New +$255K 0.02% 209

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janney Capital Management's GPCR Position: Q4 2025 in Review

Janney Capital Management reduced its Structure Therapeutics (GPCR) stake by 38% in Q4 2025, selling an estimated $213K and leaving 8,513 shares worth $592K. The position accounts for 0.04% of the portfolio, ranked #160.

Janney Capital Management first reported a position in GPCR in Q3 2024 and has held it in 4 quarters since. 197 funds tracked by Wall St. Rank hold GPCR as of Q4 2025.

  • Janney Capital Management held 8,513 shares of Structure Therapeutics worth $592K as of Q4 2025.
  • Janney Capital Management sold 5,205 Structure Therapeutics shares in Q4 2025, an estimated $213K.
  • Structure Therapeutics made up 0.04% of Janney Capital Management's portfolio in Q4 2025, its #160 holding.
  • Janney Capital Management first reported a position in Structure Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 197 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2025.

Based on Janney Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.